If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWatkin Jones Regulatory News (WJG)

Share Price Information for Watkin Jones (WJG)

Share Price is delayed by 15 minutes
Get Live Data
19.00    0.00 (0.00%)
Bid:
19.20
Ask:
19.54
Spread: 0.34 (1.771%)
Market Cap: £48.82m
WJG Live PriceLast checked at - London Stock Exchange

Intraday Watkin Jones Share Chart

Result of AGM

29 Feb 2024 17:17

RNS Number : 0476F
Watkin Jones plc
29 February 2024
 

For immediate release

29 February 2024

 

 

Watkin Jones plc

 ('Watkin Jones' or the 'Company')

 

Result of AGM

 

Watkin Jones plc (AIM:WJG) announces that at the Company's Annual General Meeting held earlier today, all resolutions were duly passed on a poll.

 

A breakdown of proxy votes lodged prior to and votes received at the meeting for each resolution is set out below and will also be made available on the Company's website.

 

 

For

No. of votes 'For' and discretionary

 

 

%

Against

%

Withheld

1

Receive the Directors' report and financial statements

 

157,560,884

 

99.98%

25,553

0.02%

21,145

2

 Approve the Directors' remuneration report

 

 

131,347,691

84.83%

23,484,347

15.17%

2,775,544

3

 Re-elect Alan Giddins as a Director

 

 

156,349,520

99.22%

1,231,451

0.78%

26,611

4

Re-elect Alex Pease as a Director

 

157,424,382

99.90%

156,589

0.10%

26,611

5

Re-elect Sarah Sergeant as a Director

 

 

157,424,317

99.90%

156,654

0.10%

26,611

6

 Re-elect Rachel Addison as a Director

 

 

157,427,317

99.90%

153,654

0.10%

26,611

7

Re-elect Liz Reilly as a Director

 

 

157,424,317

99.90%

156,654

0.10%

26,611

8

Re-elect Francis Salway as a Director

 

 

157,427,317

99.90%

153,654

0.10%

26,611

9

Appoint Deloitte LLP as auditor

 

157,438,103

99.91%

140,241

0.09%

29,238

10

Authorise the Directors to agree the remuneration of the auditor

 

157,473,784

99.93%

102,941

0.07%

30,857

11

Authorise the Directors to allot shares

 

156,716,151

99.48%

814,490

0.52%

76,941

12

Standard 5% disapplication of statutory pre-emption rights

 

157,036,053

99.68%

506,389

0.32%

65,140

13

Additional 5% disapplication of statutory pre-emption rights

 

156,965,954

99.63%

576,488

0.37%

65,140

14

Approve the purchase and cancellation of up to 10% of the issued ordinary share capital

 

129,359,005

99.89%

140,429

0.11%

28,108,148

15

Allow meetings other than annual general meetings to be called on not less than 14 clear days' notice 

157,180,691

99.74%

406,113

0.26%

20,778

 

Notes

 

1. The percentages voted 'For' and 'Against' are expressed as a proportion of the total votes cast. Votes withheld have not been included in the calculation of whether a resolution is carried since for legal purposes a vote withheld is not a vote cast.

 

2. Any proxy appointments which gave discretion to the Chair of the meeting have been included in the 'For' total.

 

3. At the date of the AGM the issued share capital of the Company was 256,441,253 ordinary shares.

 

For further information:

Watkin Jones plc

 

Alex Pease, Chief Executive Officer

Tel: +44 (0) 20 3617 4453

Sarah Sergeant, Chief Financial Officer

 

Peel Hunt LLP (Nominated Adviser & Joint Corporate Broker)

 

 

Tel: +44 (0) 20 7418 8900

Mike Bell / Ed Allsopp

www.peelhunt.com

 

Jefferies Hoare Govett (Joint Corporate Broker)

 

Tel: +44 (0) 20 7029 8000

James Umbers/David Sheehan / Paul Bundred

 

www.jefferies.com

Media enquiries:

Buchanan

 

Henry Harrison-Topham / Jamie Hooper

watkinjones@buchanan.uk.com

Tel: +44 (0) 20 7466 5000

www.buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEAXANAFSLEFA
Date   Source Headline
1st Jul 202610:21 amRNSHolding(s) in Company
1st Jul 20268:35 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSChange of Registered Office
28th May 20263:00 pmRNSInvestor Presentation via Investor Meet Company
27th May 20267:00 amRNSHalf Year Results
19th May 20267:00 amRNSNotice of H1-2026 Results
1st May 20267:00 amRNSTotal Voting Rights
29th Apr 20267:00 amRNSHY 2026 Trading Update
13th Apr 20261:50 pmRNSHolding(s) in Company
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20264:20 pmRNSHolding(s) in Company
25th Mar 20264:14 pmRNSHolding(s) in Company
11th Mar 20262:39 pmRNSHolding(s) in Company
27th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20262:00 pmRNSResult of AGM
3rd Feb 202611:46 amRNSBlocklisting Application
28th Jan 20261:26 pmRNSHolding(s) in Company
20th Jan 20267:00 amRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSAnnual Report and Notice of AGM
22nd Dec 20257:00 amRNSDevelopment Partnership for 294-unit hotel
22nd Dec 20257:00 amRNSDevelopment Partnership for 294-unit hotel
19th Dec 202512:02 pmRNS-RProgressive publishes new research
19th Dec 202512:02 pmRNS-RProgressive publishes new research
17th Dec 20258:17 amRNSPresentation via Investor Meet Company
16th Dec 20257:00 amRNSFull Year Results
15th Dec 20251:10 pmRNSWJ & Maslow Capital announce £102m PBSA scheme
21st Oct 20257:00 amRNSFY25 Trading Update
1st Oct 202510:44 amRNSHolding(s) in Company
30th Sep 20257:00 amRNSWatkin Jones announces £182m PBSA Joint Venture
10th Sep 20257:00 amRNSHolding(s) in Company
5th Sep 20257:00 amRNSAppointment of Joint Corporate Broker
4th Sep 202512:54 pmRNSHolding(s) in Company
12th Aug 20257:00 amRNSDevelopment Partnership for 200-unit PBSA scheme
1st Jul 20257:00 amRNSIssue of Sharesave options and PDMR shareholdings
29th May 20253:36 pmRNSPresentation via Investor Meet Company
29th May 20257:00 amRNSHalf Year Results
28th May 202511:56 amRNSHolding(s) in Company
22nd May 20257:00 amRNSNotice of H1-2025 Results
29th Apr 20257:00 amRNSHY25 Trading Update
4th Apr 20257:00 amRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSHolding(s) in Company
4th Mar 20254:12 pmRNSNotification of Major Holdings
4th Mar 20252:26 pmRNSResult of AGM
12th Feb 20252:11 pmRNSNotification of Major Holdings
7th Feb 20257:50 amRNSAnnual Report and Notice of AGM
5th Feb 20257:00 amRNSDirector/PDMR Shareholding
31st Jan 20259:53 amRNSDevelopment Partnership for 260-unit Aparthotel
27th Jan 20254:59 pmRNS-RPresentation via Investor Meet Company
27th Jan 20254:55 pmRNSPresentation via Investor Meet Company
27th Jan 20251:23 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.